Aripiprazole Monohydrate

Records for this ingredient, by country (identity only).

ATC N05AX12 · 3 markets · 17 records

Aripiprazole Monohydrate 3 markets · 17 records Forms
Filters
MarketAU 9TW 6SG 2

AU 9 records · 3 shown of 3 Source TGA、TGA CMI repository (consumer medic · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

  • 312.04 mg per mL / per unit basis not statedinjectionARIPENA aripiprazole 400 mg powder and diluent for prolonged release suspension for injection vial kitARIPIPRAZOLE RBX aripiprazole 400 mg powder and diluent for prolonged release suspension for injection vial kit、ARIPIPRAZOLE SANDOZ DEPOT aripiprazole 300 mg powder and diluent for prolonged release suspension for injection vial kit、ARIPIPRAZOLE SUN aripiprazole 400 mg powder and diluent for prolonged release suspension for injection vial kit unknown
  • 416.07 mg per mL / per unit basis not statedinjectionARIPENA aripiprazole 400 mg powder and diluent for prolonged release suspension for injection vial kitARIPIPRAZOLE RBX aripiprazole 400 mg powder and diluent for prolonged release suspension for injection vial kit、ARIPIPRAZOLE SUN aripiprazole 400 mg powder and diluent for prolonged release suspension for injection vial kit unknown
  • 416.06 mg per mL / per unit basis not statedinjectionARIPIPRAZOLE SANDOZ DEPOT aripiprazole 300 mg powder and diluent for prolonged release suspension for injection vial kit unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Abilify Asimtufii ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

TW 6 records · 4 shown of 4 Source 衛生福利部食品藥物管理署(TFDA)全部藥品許可證資料集 · Data as of 2026-10-22

SG 2 records · 2 shown of 2 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

  • 960 mg/3.2 mLinjection · extended-releaseABILIFY ASIMTUFII PROLONGED-RELEASE SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE 960MG/3.2ML
  • 400 mg/syringe per mL / per unit basis not statedinjection · extended-releaseABILIFY MAINTENA POWDER AND SOLVENT FOR PROLONGED RELEASE SUSPENSION FOR INJECTION IN PFS 400mg

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.